The document discusses the significant issue of medication fraud, estimating its cost at $200 billion annually and linking it to over a million annual deaths due to therapy failure, particularly in developing regions. It outlines the regulatory landscape for healthcare traceability, emphasizing the importance of blockchain technology for verifying and tracking medication supply chains. Quæfacta provides solutions to improve healthcare traceability through various technologies, including blockchain and AI.